J&J nabs Peninsula Pharmaceuticals for $245M

The privately-held Alameda company is focused on developing antibiotics to treat life-threatening infections. Its lead product, doripenem, is a broad-spectrum antibiotic in six late-stage clinical trials.

Continue to J&J nabs Peninsula Pharmaceuticals for $245M on Misc sources.

Guarantee finance is a leading newssite providing news about stocks, markets, finance, mortgage rates, refinancing, home loans, equity, consolidation and currencies. Click below for more finance news.
Guarantee finance